Sipai Health Technology Co., Ltd. (HKG:0314)
Hong Kong · Delayed Price · Currency is HKD 1.590
0.00 (0.00%)
Sep 11, 2026, 4:08 PM HKT
Sipai Health Technology Revenue
Sipai Health Technology had revenue of 739.92M CNY in the half year ending June 30, 2026, a decrease of -68.70%. This brings the company's revenue in the last twelve months to 1.59B, down -53.68% year-over-year. In the year 2025, Sipai Health Technology had annual revenue of 2.07B, down -54.64%.
Revenue (ttm)
1.59B CNY
Revenue Growth
-53.68%
P/S Ratio
0.63
Revenue / Employee
460.09K CNY
Employees
3,449
Market Cap
1.16B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.07B | -2.49B | -54.64% |
| Dec 31, 2024 | 4.57B | -146.67M | -3.11% |
| Dec 31, 2023 | 4.71B | 592.63M | 14.39% |
| Dec 31, 2022 | 4.12B | 645.55M | 18.58% |
| Dec 31, 2021 | 3.47B | 774.28M | 28.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 660.27B |
| Charmacy Pharmaceutical | 5.40B |
| ETHK Labs | 3.35B |
| Sinco Pharmaceuticals Holdings | 2.22B |
| ClouDr Group | 1.57B |
| 160 Health International | 784.99M |
| Ziyuanyuan Holdings Group | 423.08M |
| Wanjia Group Holdings | 165.39M |